Sales rise 15.67% to Rs 2173.18 crore
Net profit of Glenmark Pharmaceuticals rose 3.46% to Rs 223.59 crore in the quarter ended September 2016 as against Rs 216.11 crore during the previous quarter ended September 2015. Sales rose 15.67% to Rs 2173.18 crore in the quarter ended September 2016 as against Rs 1878.74 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales2173.181878.74 16 OPM %20.6521.49 -PBDT384.06361.94 6 PBT315.36302.93 4 NP223.59216.11 3Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
